Trump administration passed up chance to buy more Pfizer Covid-19 vaccine doses 

 
This summer, the White House opted not to lock in an additional 100 million doses for delivery in the second quarter of 2021. Days ahead of the vaccine’s expected approval, the administration is reversing course, but it is not clear if Pfizer will be able to meet the latest request on the same timeline